Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-004294
Filing Date
2020-05-14
Accepted
2020-05-14 13:40:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29465
2 filename2.txt TEXT-EXTRACT 4589
  Complete submission text file 0000000000-20-004294.txt   45856
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filed for) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations